Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

WHAT IF YOU COULD CHOOSE YOUR AGE? LANCÔME LAUNCHES A NEW ERA OF SKIN LONGEVITY WITH THE #1 SELLING UROLITHIN-A SUPPLEMENT¹, NOW IN ADVANCED SKINCARE

Lancome Logo (PRNewsfoto/Lancôme Paris)

News provided by

Lancôme

Mar 27, 2026, 09:06 ET

Share this article

Share toX

Share this article

Share toX

INTRODUCING NEW ABSOLUE LONGEVITY MD

NEW YORK, March 27, 2026 /PRNewswire/ -- Longevity is no longer just about living longer; it's about maintaining vitality, resilience, and strength as we age. Advances in science and technology now allow us to support not only lifespan, but health span: the years lived in optimal conditions.

As life expectancy increases, aging shifts from an inevitable decline to a process that can be supported, optimized, and guided.

Continue Reading
Absolue Longevity MD Collection
Absolue Longevity MD Collection
Absolue Longevity MD Intercept The Cream
Absolue Longevity MD Intercept The Cream
Absolue Longevity MD Reset The Serum
Absolue Longevity MD Reset The Serum

In beauty, this evolution means changing how we view the role of skincare entirely — expanding our perspective to encompass the visible biological signs of how skin ages, at every stage of life.

Skin is not merely aesthetic. As the body's largest organ, it reflects overall health span. While chronological age is fixed, biological age is dynamic, measurable, and influenceable. By targeting visible biological aging signs, skincare can be seen as a powerful pillar of longevity science, offering the opportunity to act on how skin's appearance evolves as we age.

LANCÔME AT THE FOREFRONT OF LONGEVITY SCIENCE

Lancôme is redefining how beauty approaches aging, shifting from "looking younger" to supporting long-term feelings of vitality and confidence.

Drawing on 90 years of scientific heritage and the advanced biological expertise of the L'Oréal Groupe, Lancôme pioneers Longevity Integrative Science™, a proactive approach that targets the visible manifestations of aging mechanisms to support renewal, resilience, and healthy-looking skin over time.

Through strategic open-innovation partnerships, including Swiss biotech company Timeline® and Korean beauty tech startup NanoEntek™, Lancôme bridges cutting-edge biotech with high-performance consumer skincare, effectively setting our standard for the beauty industry's future.

NEW ABSOLUE LONGEVITY MD
Validated by dermatologists*

Formulated with Mitopure® by Timeline — the #1 selling longevity Urolithin-A supplement1 — now introduced into advanced skincare.

Absolue Longevity MD is Lancôme's first dermatologist-validated skincare range* grounded in Longevity Integrative Science™. Designed to reverse your skin's visible biological age at every life stage, it targets visible aging signs including firmness, suppleness, radiance, fine lines, and smoothness helping to preserve the look of strength, vitality, and radiance over time.

*Validated in partnership with Lancôme's advisory board of dermatologists, ensuring thorough review of testing protocols and results; comprehensive ingredient screening for efficacy, safety, and skin compatibility.

MITOPURE® BY TIMELINE: FROM BIOTECH TO SKINCARE

A central pillar of longevity is mitochondrial health. Mitochondria generate cellular energy, enabling renewal and resilience. As skin ages, mitochondrial efficiency declines, contributing to visible signs of aging.

Mitopure® is Timeline's proprietary, highly pure form of Urolithin-A, a postbiotic widely recognized in the longevity field.

Backed by more than $50 million in R&D and 15 years of research, Mitopure® powers Timeline's supplement, recommended by a collective of longevity doctors & specialist. It enters skincare on a global scale for the first time through Lancôme.

Inspired by biotech innovation, this launch delivers high-performance topical formulas, expanding longevity skincare beyond niche applications.

THREE TARGETED INTERVENTION MODELS

Integrated across the ANTICIPATE, INTERCEPT, and RESET intervention models, Mitopure® acts as a foundational platform for the whole line. It complements each compound found in the models, helping to support the look of energized, healthy skin throughout its lifespan.

Building on this foundation, Lancôme goes beyond a single ingredient, creating proprietary compounds that balance proactive and corrective approaches differently at each stage of the skin's aging trajectory. These compounds are precisely calibrated to respond to the visible biological shifts that occur as skin evolves over time.

Each compound is a tailored blend of key ingredients, designed to meet the skin's needs based on its visible biological age—ensuring that every intervention model delivers the right solution, at the right moment.

EARLY ONSET
ANTICIPATE

SKIN'S BIOLOGICAL AGE: UNDER 35

Designed to act on visible biological aging signs before they appear.

ANTICIPATE Compound

Formulated with Mitopure®, 98.5% pure and micronized form of Urolithin-A, a postbiotic widely recognized in the longevity field1.

For a formula with targeted efficacy, Mitopure® is combined with the new proprietary and unique Anticipate compound. This complex fuses Epigenomyl®, Eperuline, Ectoin, and Rose Pro-Xylane with Taurine to anticipate specific visible skin markers according to your visible biological age—the only age you can reverse.

Clinically measured visible and invisible results

Visible aging markers: -16% Incoming fine lines2
invisible aging markers: Up to -50% Skin oxidation3

1Absolue Longevity MD provides a topical cosmetic way to combat visible signs of aging. Does not function like Mitopure® oral supplement.
2In a Clinical test after 3 months, reduces the look of emerging fine lines.
3With daily use treated vs. untreated skin.

"Targets aging signs before they appear, fortifying skin's youthful look."
– Dr. Annie Black, Lancôme International Scientific Director

MID-AGE
INTERCEPT

SKIN'S BIOLOGICAL AGE: 35–55

Designed to target visible biological aging signs as they appear.

THE INTERCEPT COMPOUND
Formulated with Mitopure®, 98.5% pure and micronized form of Urolithin-A, a postbiotic widely recognized in the longevity field1.

For a formula with targeted efficacy, Mitopure® is combined with the new proprietary and unique Intercept compound. This complex fuses LHA, Matrixyl™, Niacinamide, and Rose Pro-Xylane with Taurine to intercept specific visible skin markers according to your visible biological age—the only age you can reverse.

Clinically measured visible and invisible results

Visible aging marker: +76% skin elasticity in just 4 hours2
Invisible aging marker: +4 million new surface cells per day3

1Absolue Longevity MD provides a topical cosmetic way to combat visible signs of aging. Does not function like Mitopure® oral supplement.
2Instrumental test, 4 hours after application
3Clinical study based on exfoliation over 3 weeks vs. untreated skin

"Intercepts visible aging signs as they appear for luminous, youthful looking skin."
– Dr. Annie Black, Lancôme International Scientific Director

MORE MATURE
RESET

SKIN'S BIOLOGICAL AGE: OVER 55

Designed to reset skin's visible biological aging signs after they appear.

THE RESET COMPOUND

Formulated with Mitopure®, 98.5% pure and micronized form of Urolithin-A, a postbiotic widely recognized in the longevity field1.

For a formula with targeted efficacy, Mitopure® is combined with the new proprietary and unique Reset compound. This complex fuses Senevisium®, Rhamnose, Niacinamide, and Rose Pro-Xylane with Taurine to reset specific visible skin markers according to your visible biological age—the only age you can reverse.

Clinically measured visible and invisible results

Visible aging marker: +55% skin bounce2
Invisible aging marker: +15% faster surface cell renewal3

1Absolue Longevity MD provides a topical cosmetic way to combat visible signs of aging. Does not function like Mitopure® oral supplement.
2Instrumental Test, 4 hours after application
3Clinical study based on exfoliation over 3 weeks vs. untreated skin

"Reverses visible signs of damage to help restore skin's look of vitality."
– Dr. Annie Black, Lancôme International Scientific Director

Lancôme's Longevity MD range is available from April 20th, at Lancome-usa.com and select luxury retailers nationwide on May 1st.

  • Anticipate
    • The Cream 1.7 fl. Oz at MSRP $155
  • Intercept
    • The Serum 1.7 fl. Oz. at MSRP $175
    • The Cream 1.7 fl. Oz. at MSRP $155
  • Reset
    • The Serum 1.7 fl. Oz. at MSRP $175
    • The Cream 1.7 fl. Oz. at MSRP $155

About Lancôme

Founded in 1935 by the visionary pioneer Armand Petitjean, with the wish of spreading the spirit and taste of French elegance around the world, Lancôme immediately embodied the essence of beauty. More than ever before, the brand aims to offer every woman the possibility to blossom and embrace her beauty and femininity whatever her age or skin color. Lancôme is present in 135 countries, with about 20,000 beauty advisers in as many points of sale offering sophisticated services and iconic products to an international clientele. Lancôme successfully combines scientific expertise and an intuitive understanding of women's needs to produce major innovations, unique and complementary between skincare, makeup and perfume. Lancôme affirms that happiness is the most attractive beauty. To embody that the brand has chosen charismatic and fully accomplished women such as Julia Roberts, Isabella Rossellini, Olivia Rodrigo, Christy Turlington, and Vanessa Kirby.

For more information, please visit www.Lancome-usa.com or follow us on Instagram: @lancomeofficial, TikTok: @lancome.official, YouTube: @lancomeusa or Facebook: LancomeUS.

Leah Pitman, Head of PR & Partnerships – [email protected]

Alison Brod Marketing & Communications – [email protected]

SOURCE Lancôme

21%

more press release views with 
Request a Demo

Modal title

Also from this source

LANCÔME NAMES DEMI MOORE AS GLOBAL AMBASSADOR

LANCÔME NAMES DEMI MOORE AS GLOBAL AMBASSADOR

Her resilience, bravery, and self-determination inspire women everywhere: Lancôme welcomes Demi Moore to its Collective of Global Ambassadors. The...

LANCÔME WELCOMES ZOE SALDAÑA AS GLOBAL AMBASSADOR

LANCÔME WELCOMES ZOE SALDAÑA AS GLOBAL AMBASSADOR

Her presence in every role reflects her modern femininity and radiant confidence: Lancôme welcomes Zoe Saldaña to its Collective of Global...

More Releases From This Source

Explore

Cosmetics and Personal Care

Cosmetics and Personal Care

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

Retail

Retail

Health Care & Hospitals

Health Care & Hospitals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.